Breastcancer.org Podcast

Latest Episodes:

2014 San Antonio Breast Cancer Symposium Research Highlights Oct 19, 2016

Show notes

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was presented at the 2014 San Antonio Breast Cancer Symposium.

Listen to the podcast to hear Dr. Wojciechowski explain:

results of a study that found that Aromasin plus ovarian suppression reduced recurrence risk better than tamoxifen plus ovarian suppression in some women diagnosed with early-stage, hormone-receptor-positive disease
research that underscored the long-term benefits of tamoxifen for reducing risk in women with a higher-than-average risk of breast cancer who’ve never been diagnosed
a study showing that Faslodex worked better than Arimidex as a first treatment for women newly diagnosed with advanced-stage breast cancer
research conducted in part by Breastcancer.org that shows that breastfeeding, even for a short time, reduces breast cancer risk more than previously thought
why a low-fat diet improved survival in women diagnosed with hormone-receptor-negative breast cancer

February 2015 Research Highlights Oct 19, 2016

Show notes

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, discusses Ibrance, a medicine that was approved to treat metastatic, hormone-receptor-positive breast cancer in February 2015.

Listen to the podcast to hear Dr. Wojciechowski explain:

how Ibrance works
who is eligible to take Ibrance
how Ibrance is taken and whether any other medicines are taken with it
the side effects that Ibrance can cause

March 2015 Research Highlights Oct 19, 2016

Show notes

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, discusses a study looking at whether Zoladex (chemical name: goserelin) given during chemotherapy can help preserve fertility in premenopausal women diagnosed with early-stage, hormone-receptor-negative breast cancer.

Listen to the podcast to hear Dr. Wojciechowski explain:

when Zoladex is given
why women shouldn’t get pregnant while they’re being treated with chemotherapy and Zoladex
why a woman might have to bring this treatment up with her doctor
why this treatment is only recommended for women diagnosed with early-stage, hormone-receptor-negative disease

Holley Kitchen, "Cancer Lifer," Talks Metastatic Disease and Her Viral Video Oct 19, 2016

Show notes

This Breastcancer.org podcast features Holley Kitchen, the metastatic “cancer lifer” as she calls herself, whose June 4, 2015 video about what it’s like to live with metastatic breast cancer went viral on Facebook and other media outlets. Holley was diagnosed with stage III breast cancer in 2012. In 2013, she learned that the cancer had recurred in her spine and other bones.

Listen to the podcast to hear Holley talk about:

why and how she made her now-famous video
her support group of other younger women with metastatic disease and why it’s so important to her
some of the most common misconceptions about metastatic disease
what she’s doing next

Marie Arsenault, Metastatic Patient, Talks About the Need for a Cure, Not Awareness Oct 19, 2016

Show notes

This Breastcancer.org podcast features Marie Arsenault, a former music promoter and booking agent, who was first diagnosed with stage II estrogen-receptor-positive, HER2-negative breast cancer in September 2000 at age 36. She had mastectomy with TRAM flap reconstruction, chemotherapy, and radiation. In May 2007, she was diagnosed with metastatic disease; the breast cancer had returned in her liver and bones. In 2011, the cancer spread to her bone marrow.

Listen to the podcast to hear Marie talk about:

how she feels during Breast Cancer Awareness Month
what she would like people to know about metastatic breast cancer
how her support network helps her stay positive through treatment
her volunteer work with the Tenth Life Cat Rescue in St. Louis

Research Highlights From the 2015 San Antonio Breast Cancer Symposium Oct 19, 2016

Show notes

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, talks about four studies that were presented at the 2015 San Antonio Breast Cancer Symposium, December 8-12, including studies that offer encouraging news about treatment for women diagnosed with triple-negative disease and metastatic, HER2-positive breast cancer.

Listen to the podcast to hear Dr. Wojciechowski explain:

what luminal A breast cancer is and why women diagnosed with this subtype didn’t seem to benefit from chemotherapy after surgery
why adding carboplatin to a standard chemotherapy before surgery for triple-negative breast cancer improved pathologic complete response rates and what this means for women with triple-negative disease
why postmenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer who are taking an aromatase inhibitor and have experienced bone loss might want to consider taking the targeted therapy denosumab
results showing that Kadcyla improves overall survival in women diagnosed with metastatic, HER2-positive breast cancer that has stopped responding to Herceptin and Tykerb

2015 San Antonio Breast Cancer Symposium: Arimidex, Tamoxifen, and Recurrence Risk After DCIS Oct 19, 2016

Show notes

In this podcast, Marisa Weiss, M.D., Breastcancer.org’s chief medical officer, explains a study that looked at the effectiveness of Arimidex and tamoxifen for reducing risk after DCIS surgery and radiation, as well as the side effects of each medicine. The study was presented at the 2015 San Antonio Breast Cancer Symposium, December 8-12.

Listen to the podcast to hear Dr. Weiss explain:

what DCIS is
why postmenopausal women should be reassured no matter which of these medicines they’re taking
the side effects of each medicine

2015 San Antonio Breast Cancer Symposium: Lumpectomy Plus Radiation vs. Mastectomy for Early-Stage Disease Oct 19, 2016

Show notes

In this Breastcancer.org podcast, Marisa Weiss, M.D., Breastcancer.org’s chief medical officer, discusses a study examining survival rates after lumpectomy plus radiation or mastectomy for early-stage breast cancer. The study was presented at the 2015 San Antonio Breast Cancer Symposium Dec. 8-12.

Listen to the podcast to hear Dr. Weiss explain:

why lumpectomy plus radiation and mastectomy are both good choices for early-stage breast cancer surgery
why one type of surgery might be recommended over the other
why the researchers think there might have been a difference in survival rates

Precision Medicine and the “Moonshot” Program Oct 19, 2016

Show notes

Nancy Davidson, M.D., is director of the University of Pittsburgh Cancer Institute, where she also is a distinguished professor of medicine and associate vice chancellor for cancer research. She also serves as president-elect of the American Association for Cancer Research, the first and largest cancer research organization in the world. Dr. Davidson is a world-renowned breast cancer researcher who has played a key role in discovering how hormones, particularly estrogen, affect cell growth in breast cancer.

Listen to the podcast to hear Dr. Davidson explain:

what the American Association for Cancer Research is and what its goals are
what precision medicine is
what she thinks the moonshot program to conquer cancer will do
what new treatments she sees coming in the near future

All About Cold Caps Oct 19, 2016

Show notes

Hope Rugo, M.D. is a medical oncologist specializing in breast cancer research and treatment. A professor of medicine at the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, Dr. Rugo is the director of the Breast Oncology Clinical Trials Program and is the lead researcher on a number of studies investigating new treatments for both early-stage and metastatic breast cancer. Dr. Rugo is a member of the Breastcancer.org Professional Advisory Board. She also was the lead researcher on the study that led to the U.S. Food and Drug Administration approval of the DigniCap, a cold cap that may help some women keep some or quite a bit of hair during chemotherapy.

Listen to the podcast to hear Dr. Rugo explain:

how she became interested in studying cold caps
how cold caps work
her research on the DigniCap
how much cold caps might cost and whether insurance is covering it yet

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected